Type 2 diabetes mellitus burdens among adults with sickle cell disease: A 12‐year single health system‐based cohort analysis

Míreanna comhchosúla

• Evaluation of point‐of‐care International Normalized Ratio in sickle cell disease
  de réir: Syeda Rahman, et al.
  Foilsithe / Cruthaithe: (2021-05-01)
• Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease
  de réir: Claudia Rodriguez Rivera, et al.
  Foilsithe / Cruthaithe: (2023-02-01)
• Economic burden of sickle cell disease in Brazil.
  de réir: Ana Cristina Silva-Pinto, et al.
  Foilsithe / Cruthaithe: (2022-01-01)
• Economic burden of sickle cell disease in Brazil
  de réir: Ana Cristina Silva-Pinto, et al.
  Foilsithe / Cruthaithe: (2022-01-01)
• Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
  de réir: Jin Han, et al.
  Foilsithe / Cruthaithe: (2021-08-01)